Lexaria Bioscience Corp (NASDAQ:LEXX) shares are trading lower by 6.5% to $2.43 Thursday morning after the company finalized agreements for a registered direct offering of 1,558,443 shares of common stock at $2.31 per share.
Additionally, the company will conduct a concurrent private placement, issuing unregistered warrants for the purchase of up to 1,558,443 shares of common stock at an exercise price of $2.185 per share. The offering is expected to close around February 16.
H.C. Wainwright ...
LEXX) Shares Are Moving>Full story available on Benzinga.com